PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.220
+0.010 (0.83%)
At close: Dec 5, 2025, 4:00 PM EST
1.150
-0.070 (-5.74%)
After-hours: Dec 5, 2025, 7:59 PM EST
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$22,227
Market Cap
8.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PMCB News
- 10 days ago - PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Business Wire
- 3 months ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 3 months ago - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Business Wire
- 3 months ago - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Business Wire
- 1 year ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 1 year ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 2 years ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 2 years ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire